Poster Abstract Session:
136. Clostridium difficile Infections: Epidemiology and Diagnostics
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID, Pediatric ID, Epidemiology and Infection Control

Presentations:
915
Hospital Incidence of Clostridium difficile Infection (CDI) as a Risk Factor for Hospital-Associated CDI
Aaron Miller, PhD ; Linnea Polgreen, PhD ; Joseph Cavanaugh, PhD ; Philip M. Polgreen, MD
Posters
  • Presure_Paper_Poster2.pdf (677.6 kB)
  • 916
    Risk Factors for Community-Associated Clostridium Difficile Infection: a Case Control Study
    Susan N. Hocevar, MD ; Sandra N. Bulens, MPH ; Monica Farley, MD, FIDSA ; Stacy Holzbauer, DVM, MPH, DACVPM ; Emily B. Hancock, MS ; Ghinwa Dumyati, MD, FSHEA ; Corinne M. Davis, MPH ; Carol Lyons, MPH ; Rebecca Perlmutter, MPH ; Erin Parker, MPH ; Claire Reisenauer, DVM ; Valerie L.S. Ocampo, RN, MIPH ; Yi Mu, PhD ; L. Clifford Mcdonald, MD, FSHEA
    917
    Independent Risk Factors for Recurrence of Clostridium difficile Infection: A Canadian Multicenter Prospective Cohort
    Claire Nour Abou Chakra, MSc ; Allison Mcgeer, MD, MSc, FRCPC, FSHEA ; Annie-Claude Labbé, MD, FRCPC ; Andrew E. Simor, MD, FRCPC, FACP, FIDSA, FSHEA ; Wayne Gold, MD ; Matthew P. Muller, MD, PhD, FRCPC ; Jeff Powis, MD, MSc, FRCPC ; Kevin Katz, MD, CM, MSc, FRCPC ; Julian R. Garneau, BSc ; Louis-Charles Fortier, PhD ; Jacques Pepin, MD, MSc ; Louis Valiquette, MD, MSc
    918
    Molecular and Clinical Epidemiology of Clostridium difficile Infection (CDI) in Three Diverse Medical Centers in New York
    Marisa Montecalvo, MD ; Mini Kamboj, MD ; Donna Mckenna, ANP MS ; Jonathan Menz, MBA ; Liz Klimczak, RN MS ; Melody Zolendjeski, RN ; Guiqing Wang, MD, PhD ; Gary Wormser, MD, FIDSA
    Posters
  • IDSAPoster10_01_2015PDF.pdf (412.1 kB)
  • 919
    Trends in the incidence of Clostridium difficile infections and NAP1/027 strain in the elderly population of Monroe County, NY
    Ghinwa Dumyati, MD, FSHEA ; Jennifer Berry, MPH ; Rebecca Tsay, MPH, MLS ; Deborah Nelson, MSN, RN ; Anita Gellert, RN
    Posters
  • poster IDweek 2015 final.pdf (138.9 kB)
  • 920
    Geographic Distribution of Clostridium difficile Infection Burden by Various Counties in Michigan
    Babbaljeet Kaur, MD ; Paul Kilgore, MD, MPH ; Abdulbaset Salim, MD, MPH ; Elizabeth Waldman, MPH ; Gloria E. Pizzo, RN/BSN ; Harolyn Baker, MPH ; Jackie Rosenblatt, PhD ; Keith Kaye, MD, MPH, FIDSA, FSHEA ; Teena Chopra, MD, MPH
    Posters
  • IDSA poster.pdf (491.1 kB)
  • 921
    Candida Co-infection among Adults with Clostridium difficile Infection in Metropolitan Atlanta, 2009„Ÿ2013
    Snigdha Vallabhaneni, MD, MPH ; Olivia M. Almendares, MSPH ; Monica Farley, MD, FIDSA ; Jessica Reno, MPH ; Zirka Smith, MPH ; Betsy Stein, RN, BSN ; Shelley S. Magill, MD, PhD ; Rachel M. Smith, MD, MPH ; Angela Cleveland, MPH ; Fernanda C. Lessa, MD
    923
    Consensus Definition of Clostridium Difficile Infections That Are Not Preventable by Antibiotic Stewardship Programs
    Jessica Seidelman, M.D. ; Kristen V. Dicks, MD ; Sarah S. Lewis, MD MPH ; Michael J. Durkin, MD, MPH ; Arthur W. Baker, MD, MPH ; Rebekah W. Moehring, MD, MPH ; Deverick Anderson, MD, MPH, FIDSA, FSHEA ; Daniel J. Sexton, MD, FIDSA, FSHEA ; Luke F. Chen, MBBS, MPH, CIC, FRACP
    924
    Case Vignettes to Analyze Physician and Nurse Decision-making regarding Clostridium difficile Infection
    Nasia Safdar, MD, PhD, FSHEA ; Rebekah Blakney, MS ; Robert Wigton, MD ; Eric Yanke, MD
    925
    Mixed infection as a cause of relapsing Clostridium difficile associated disease
    Janet Sun, BS ; Tracy Mcmillen, BS ; N. Esther Babady, Ph.D ; Mini Kamboj, MD
    Posters
  • Recurrent C. diff Poster 2.pdf (91.7 kB)
  • 927
    Harnessing granular data from comprehensive electronic medical records for prediction of recurrent Clostridium difficile infection – challenges and opportunities
    Gabriel Escobar, MD ; Jennifer Baker, B.S. ; John Greene, M.A. ; Juan Carlos Laguardia, M.S. ; Nicole Cossrow, MPH, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
    Posters
  • 927_IDWPOSTER.pdf (444.7 kB)
  • 928
    Relationship Between Continued Antibiotic Use and All-cause Mortality in Hospital-onset Clostridium difficile Associated Diarrhea
    Bert K. Lopansri, MD ; Rajesh Mehta, R.Ph, MS ; Edward Stenehjem, MD MSc ; Kristin Dascomb, MD, PhD ; John Burke, MD, FIDSA, FSHEA
    Posters
  • C diff all cause mortality.pdf (586.4 kB)
  • 929
    The role of Clostridium difficile infection in infancy as a risk factor of childhood atopy
    Eell Ryoo, M.D. ; Yunna Gong, Medical student ; Hann Tchah, M.D.
    930
    Risk Factors and Epidemiology of Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients During the Peri-transplant Period
    Sol Aldrete, MD ; Colleen Kraft, MD ; Matthew Magee, Ph.D. ; Austin Chan, MD ; Rachel Friedman-Moraco, MD
    931
    The Epidemiology of Clostridium difficile Infections among Oncology Patients
    Yunyoung Gina Chang, M.P.H. ; Louise Dembry, MD, MS, MBA, FSHEA ; David Banach, M.D., M.P.H., M.S.
    Posters
  • IDWeek - Poster V2.pdf (1.9 MB)
  • 932
    Risk Factors for Recurrent Clostridium difficile Infection among Allogenic Stem Cell Transplant Recipients
    Marcela Ferrada, M.D. ; Ninet Sinaii, Ph.D., M.P.H. ; David K. Henderson, M.D. ; Tara N. Palmore, M.D.
    933
    Risk Factors for Clostridium difficile Infection Recurrence
    Sujan C. Reddy, MD ; Alice Guh, MD, MPH ; Fernanda C. Lessa, MD ; Yi Mu, PhD ; Zintars G. Beldavs, MS ; Corinne M. Davis, MPH ; Ghinwa Dumyati, MD, FSHEA ; Stacy M. Holzbauer, DVM, MPH ; Helen L. Johnston, MPH ; Carol Lyons, MPH ; Erin C. Phipps, DVM, MPH ; Lucy E. Wilson, MD ; Lisa G. Winston, MD ; Dale N. Gerding, MD, FIDSA ; L. Clifford Mcdonald, MD, FSHEA ; Monica Farley, MD, FIDSA
    934
    Clostridium difficile and Surgery: A multi-center observational evaluation
    Mandelin Cooper, Pharm.D., BCPS ; John Hammer, MD ; Brent Morris, Pharm.D., M.B.A ; Gary Winfield, MD
    Posters
  • 934_IDWPOSTER.pdf (265.6 kB)
  • 935
    Serum Inflammatory Mediator Profiles Differentiate Patients with Complicated and Uncomplicated Clostridium difficile Infection
    Krishna Rao, MD, MS ; Kavitha Santhosh, MD ; Jill Mogle, LPN ; Andrezj T. Galecki, MD, PhD ; Peter D. R. Higgins, MD, PhD ; Vincent B. Young, MD, PhD, FIDSA
    936
    Fecal Biomarkers of Clostridium Difficile (CD) Associated Disease (CDAD)
    Xunyan Ye, PhD ; Meina Zhao, PhD ; Alejandro Restrepo, M.D. ; John Van, BA ; Todd M. Lasco, PhD ; Kevin W. Garey, PharmD, M.S. ; Herbert Dupont, MD, FIDSA ; Hoonmo L. Koo, MD, MPH
    Posters
  • IDWeek 2015.pdf (111.3 kB)
  • 938
    The Food of Hospitalized Patients as a Risk Factor for Acquisition of Clostridium difficile: A Modeling Study
    Jennie H. Kwon, D.O. ; Cristina Lanzas, DVM, PhD ; Kimberly Reske, MPH ; Tiffany Hink, BS ; Sondra Seiler, BA ; Carey-Ann D. Burnham, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
    939
    Home narcotic use and severity of CDI ?
    Nongnooch Poowanawittayakom, MD
    Posters
  • CDI_IDSA.jpg (685.2 kB)
  • 940
    Hospital Underutilization of Present on Admission Indicators for Hospital-Acquired Clostridium difficile Infection
    Aaron Miller, PhD ; Linnea Polgreen, PhD ; Joseph Cavanaugh, PhD ; Philip M. Polgreen, MD
    Posters
  • POA_PosterIDweek2.pdf (347.7 kB)
  • 941
    The effect of body mass index on the risk of Clostridium difficile infection in persons with inflammatory bowel disease
    Amanda Thornton, MD ; Gregory Patts, MPH ; Janice Weinberg, ScD ; Nahid Bhadelia, MD, MA
    942
    Is Clostridium difficile Infection a Risk Factor for Subsequent Bloodstream Infection?
    Robert J. Ulrich, MD ; Krishna Rao, MD, MS ; Kavitha Santhosh, MD ; Jill Mogle, LPN ; Vincent B. Young, MD, PhD, FIDSA
    Posters
  • IDSAposter-FINAL.pdf (597.9 kB)
  • 943
    Bacteremia associated with Clostridium difficile colitis: Incidence, risk factors, and outcomes
    Andrea Censullo, MD ; Jonathan Grein, MD ; Meghan Madhusudhan, MPH ; Rekha Murthy, MD, FIDSA, FSHEA
    Posters
  • C difficile poster FINAL.pdf (897.9 kB)
  • 944
    Pseudo-Epidemic Clostridium difficile and Laxative Use
    Sagar Batajoo, MD ; Jeanine Weber, RN ; Jaime Fried, BSN, RN ; Kelly Brady, NP ; Adam Baghban, MD ; Rebecca Schwartz, PhD ; Barbara Edwards, MD ; Bruce Hirsch, MD
    Posters
  • 944_IDWPOSTER.pdf (1.4 MB)
  • 945
    Characteristics of fecal microbiota in Korean patients with Clostridium difficile associated diarrhea
    Hea Won Ann, MD ; Jin Young Ahn, MD ; Young Soun Lim, M.S ; Mi-Young Ahn, MD ; Yong Duk Jeon, MD ; In Young Jung, MD ; Nam Su Ku, MD ; Dongeun Yong, MD, PhD ; Kyungwon Lee, MD, PhD ; June Myung Kim, MD, PhD ; Jun Yong Choi, MD, PhD
    946
    Clinical Characteristics and Outcomes of Clostridium difficile Infection among Elderly Patients: A Multicenter Study in Japan
    Mayu Hikone, M.D. ; Yusuke Ainoda, M.D., Ph.D. ; Kenichiro Kobayashi, M.D. ; Noritaka Sekiya, M.D. ; Hanako Kurai, M.D. ; Akifumi Imamura, M.D.
    948
    Use of the Cepheid Xpert C.difficile/Epi Assay to Identify the Epidemic Strain of Clostridium difficile
    Stanley Giddings, MD ; Michaela Gazdik, PHD ; John Burke, MD, FIDSA, FSHEA ; Bert K. Lopansri, MD
    Posters
  • ID week C diff Xpert.pdf (596.3 kB)
  • 949
    The Significance and Utility of a Highly Sensitive PCR Test for the Diagnosis of Clostridium difficile Infection (CDI)
    Becky Smith, MD ; Edward Schaefer, DO ; Emelline Liu, MSHS ; Michele Schoonmaker, PhD ; Jessica Ridgway, MD ; Ari Robicsek, MD ; Lance Peterson, MD, FIDSA, FSHEA
    Posters
  • IDSA 2015 CDI poster final.pdf (565.5 kB)
  • 950
    Evaluation of the performance of the Target Enriched Multiplex Polymerase Chain Reaction (TEM-PCR) Gastrointestinal (GI) Panel vs the Cepheid Xpert C. difficile/Epi assay for the detection of toxigenic Clostridium difficile
    Khushdeep Chahal, MD ; Esmeralda Gutierrez-Asis, MD ; Farrah Ibrahim, MD FACP ; Elena Grigorenko, PhD ; Stefan Brzezinski, MBA, BS ; Donald Stalons, PhD, D(ABMM), MPH ; Ali Hassoun, MD FIDSA FACP
    951
    Toxin Gene Nucleic Acid Amplification Test Cycle Threshold Result is Associated with Severity of C. difficile Infection and Poor Patient Outcomes
    Kerrie Davies, MSc ; Timothy Planche, MD ; Nan Shetty, MD ; Mike Wren, PhD ; Derrick Crook, Professor ; Mark Wilcox, MD
    952
    Detection of Clostridium difficile by Real-Time Polymerase Chain Reaction in Young Children Does Not Predict Diarrhea
    Barbara Pahud, MD MPH ; Christopher Harrison, M.D., FSHEA, FPIDS ; Ferdaus Hassan, PhD ; Natasha Halasa, MD, MPH, FPIDS ; James D. Chappell, MD, PhD ; Janet Englund, MD, FIDSA ; Eileen Klein, MD, MPH ; Peter G Szilagyi, MD, MPH ; Geoffrey Weinberg, MD, FIDSA, FPIDS ; Christopher Polage, MD ; Mary E. Wikswo, MPH ; L. Clifford Mcdonald, MD, FSHEA ; Daniel Payne, PhD, MSPH ; Rangaraj Selvarangan, PhD
    953
    Relevance of Indeterminate Clostridium difficile (CD) Toxin Tests with positive CD PCR
    Gordana Simeunovic, MD ; Riad Khatib, MD, FIDSA ; Mamta Sharma, MD, FIDSA
    954
    In Vivo Correlation Between Clostridium difficile Toxin and Spore levels in Symptomatic CDI Patients
    Natalia Blanco, MPH ; Anurag Malani, MD, FIDSA ; Marisa Eisenberg, PhD, MS ; Alexander Rickard, PhD, MSc, BSc ; Seth Walk, PhD ; Betsy Foxman, PhD, FIDSA
    Posters
  • IDweek_Poster1004.pdf (572.6 kB)
  • 955
    Laxative Use and Testing Delays May Overestimate the True Burden of C. difficile
    Stephen Rineer, BS ; Justin Dizon, BS ; Julia Logan, PharmD ; Vincent Hsu, MD MPH FACP
    956
    Laxative Use and Clostridium difficle Testing and Treatment
    Leila Tehrani, PharmD ; Maria Teresa Seville, MD, FSHEA

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.